Effects of Two Hypertrophic Cardiomyopathy Mutations in α-Tropomyosin, Asp175Asn and Glu180Gly, on Ca2+Regulation of Thin Filament Motility
- 30 July 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 236 (3) , 760-764
- https://doi.org/10.1006/bbrc.1997.7045
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Codon 102 of the Cardiac Troponin T Gene Is a Putative Hot Spot for Mutations in Familial Hypertrophic CardiomyopathyCirculation, 1996
- Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action.Journal of Clinical Investigation, 1996
- Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1996
- Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscleNature Genetics, 1996
- Cardiac myosin binding protein–C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathyNature Genetics, 1995
- Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathyNature Genetics, 1995
- The troponin complex and regulation of muscle contractionThe FASEB Journal, 1995
- Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic CardiomyopathyNew England Journal of Medicine, 1995
- α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomereCell, 1994
- The role of tropomyosin-troponin in the regulation of skeletal muscle contractionJournal of Muscle Research and Cell Motility, 1986